Supply Issues in Nuclear Medicine

Jadvar, Delara A; Colletti, Patrick M.

doi:10.1097/rlu.0000000000004510

Clin Nucl Med

2022

DOI: 10.1097/rlu.0000000000004510

|View full text |Cite

Supply Issues in Nuclear Medicine

Delara A Jadvar

Patrick M. Colletti²

Abstract: Issues related to the distribution and availability of supplies and personnel in nuclear medicine are well known and episodic. The combination of COVID-related restrictions and the unprecedented growth of our specialty have acutely exacerbated these supply and demand mismatches.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Lan,

Lin,

Chen

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

Background Drug shortage is a worldwide problem that seriously threatens public health. China released the most comprehensive list of key drug shortage monitoring varieties ever in 2022. We aim to analyze the attributes and characteristics of the medicines within the list to provide a reference for improving China’s supply security of shortage drugs. Methods We used public data to extract information on drug types, dosage forms, indications, classification of clinical uses, whether they were included in medical catalogs such as the National Essential Drugs, and the number of drug and active pharmaceutical ingredient (API) manufacturers. A descriptive statistical analysis was used. Results Of the 980 drugs on the list, 99.59% were chemicals and 92.65% were injectables. Drugs for blood and hematopoietic organs, the cardiovascular system, and the digestive tract and metabolism ranked among the top three shortages. Verification of the medical catalogs showed that 90.41% of the drugs belonged to the national essential drugs, 95.10% were medicare drugs, 2.55% were volume-based procurement drugs, and 14.70% were for rare diseases, and 42.04% were for children. In terms of drug supply capacity, 21.33% of drug approvals are less than 10, and there were even 26 drugs for exclusive production, close to 90% of manufacturers need to purchase APIs from outside. Among the 256 APIs included in the list, 152 APIs had less than 10 manufacturers, and there were even 5 APIs produced by only one enterprise nationwide. Conclusions The situation of drug shortages in China was severe and complex, with serious shortages of medicines adapted to basic medical and healthcare needs and clinically necessary medicines, and a need to improve the production capacity of drugs and the ability to supply APIs. We recommend strengthening drug monitoring and stockpiling and accelerating the approval of shortage drugs to improve drug supply security.

show abstract

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Lan,

Lin,

Chen

et al. 2024

BMC Public Health

View full text Add to dashboard Cite

show abstract

Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities

Fraum,

Sari,

Dias

et al. 2024

American Journal of Roentgenology

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Supply Issues in Nuclear Medicine

Abstract: Issues related to the distribution and availability of supplies and personnel in nuclear medicine are well known and episodic. The combination of COVID-related restrictions and the unprecedented growth of our specialty have acutely exacerbated these supply and demand mismatches.

Cited by 2 publications

References 13 publications

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Drug supply and assurance: a cross-sectional study of drug shortage monitoring varieties in China

Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities

Contact Info

Product

Resources

About